This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mauras, N. Articles by Haymond, M. W. Search for Related Content PubMed PubMed Citation Articles by Mauras, N. Articles by Haymond, M. W.

Ovarian Hyperandrogenism Is Associated with Insulin Resistance to Both Peripheral Carbohydrate and Whole-Body Protein Metabolism in Postpubertal Young Females: A Metabolic Study¹

Nemours Children’s Clinic, Jacksonville, Florida 32207

Address all correspondence and requests for reprints to: Nelly Mauras, Nemours Children’s Clinic, 807 Nira Street, Jacksonville, Florida 32207. E-mail: nmauras{at}nemours.org

The role of endogenous androgens in enhancing the body’s protein anabolic capacity has been controversial. To examine this question we chose to study whole-body protein and glucose kinetics in a group of 21 young, postpubertal females (16.3 ± 0.6 yr), 8 of whom had clinical and laboratory evidence of ovarian hyperandrogenism (OH) (BMI = 37.8 ± 1.3 kg/m²). We used L-[1-¹³C]leucine and [6,6,²H₂]glucose tracer infusions before and after suppression of their endogenous androgens with estrogen/progesterone supplementation in the form of Triphasil for 4 weeks. Their baseline data were also compared with those of similar aged girls, 7 obese (OB) (BMI = 36.4 ± 1.5) and 6 lean (LN) (BMI = 20.9 ± 0.7) who were normally menstruating and had no evidence of androgen excess. Despite comparable glucose concentrations, both OH and OB groups had significant hyperinsulinemia (OH > OB), both basally and after iv glucose stimulation, as compared to LN controls (basal insulin: OH, 252 ± 52 pmol/L; OB, 145 ± 41; LN, 60 ± 9, P = 0.009 OH vs. LN; peak insulin: OH, 2052 ± 417; OB, 1109 ± 127, LN, 480 ± 120, P = 0.0009 OH vs. LN). The rate of appearance (Ra) of glucose, a measure of glucose production, was greater in the LN controls than in the OH or OB groups (OH, 2.0 ± 0.1 mg/kg·fat free mass·min; OB, 1.9 ± 0.1; LN, 3.3 ± 0.1, P < 0.004 vs. LN). Calculated total rates of whole-body protein breakdown (leucine Ra), oxidation, and protein synthesis (nonoxidative leucine disposal) were substantially higher in the OH and OB groups as compared with LN controls (P < 0.04 vs. LN); however, when data are expressed on a per kilogram of fat free mass basis, the OH group had higher rates of proteolysis than the OB and LN, with indistinguishable rates between the latter two groups. None of the above-mentioned parameters changed after 1 month of administration of Triphasil, despite marked improvement in circulating testosterone and free testosterone concentrations after treatment (testosterone, -50%, P = 0.003; free testosterone, -70%, P = 0.02).

We conclude that obesity in young postpubertal females is associated with insulin resistance for both peripheral carbohydrate and protein metabolism, and that patients with the OH syndrome have even greater insulin resistance as compared with simple obesity, regardless of treatment for the androgen excess. Carefully designed studies targeting interventions to improve both the hyperandrogenic and hyperinsulinemic state may prove useful even in the early juvenile stages of this disease.

This article has been cited by other articles:

				J. Sheeder, S. H. Travers, and C. Stevens-Simon Is This Patient Insulin Resistant? How Much Does It Matter? Clinical Pediatrics, November 1, 2003; 42(9): 835 - 839. [PDF]

				N. Mauras, K. O. O’Brien, S. Welch, A. Rini, K. Helgeson, N. E. Vieira, and A. L. Yergey Insulin-Like Growth Factor I and Growth Hormone (GH) Treatment in GH-Deficient Humans: Differential Effects on Protein, Glucose, Lipid, and Calcium Metabolism J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1686 - 1694. [Abstract] [Full Text]

				L. Poretsky, N. A. Cataldo, Z. Rosenwaks, and L. C. Giudice The Insulin-Related Ovarian Regulatory System in Health and Disease Endocr. Rev., August 1, 1999; 20(4): 535 - 582. [Abstract] [Full Text] [PDF]

				P. Balagopal, S. Sweeten, and N. Mauras Increased synthesis rate of fibrinogen as a basis for its elevated plasma levels in obese female adolescents Am J Physiol Endocrinol Metab, April 1, 2002; 282(4): E899 - E904. [Abstract] [Full Text] [PDF]